Position in ABBV
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$1,477,126
+$66,486 QoQ
Shares Held
5,870
-9.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.46%
of 13F equity value
Holder Rank
#2,188
of 4,153 holders
Holding Since
Sep 2021
12 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Syverson Strege & Co holds $6,588,529 across 9 Drug Manufacturers - General names. ABBV ranks #2 (22.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
6,303 | $1,600,772 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
5,870 | $1,477,126 | |
| 3 | LLY |
ELI LILLY & Co
|
932 | $1,117,868 | |
| 4 | MRK |
Merck & Co., Inc.
|
4,483 | $576,065 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
8,978 | $517,312 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
3,341 | $422,101 | |
| 7 | NVS |
Novartis AG
|
1,964 | $307,798 | |
| 8 | PFE |
Pfizer Inc
|
12,702 | $305,864 |
All Filings in ABBV
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,477,126 | 5,870 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $1,410,640 | 6,486 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $1,502,093 | 6,574 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $1,504,546 | 6,498 | Shares | Sole | 2025-12-01 | |
| 2025-06-30 | $1,114,833 | 6,006 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $962,115 | 4,592 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $809,245 | 4,554 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $641,810 | 3,250 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $695,685 | 4,056 | Shares | Sole | 2024-08-07 | |
| 2022-06-30 | $11,487 | 75 | Shares | Sole | 2022-08-11 | |
| 2021-12-31 | $2,708 | 20 | Shares | Other | 2022-01-19 | |
| 2021-09-30 | $3,128 | 29 | Shares | Sole | 2021-11-02 | |
| No filing history on record for this holder in this stock. | ||||||